Literature DB >> 18025146

GOLD stage I is not a COPD risk factor.

Paul L Enright.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 18025146      PMCID： PMC2094304     

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  7 in total

1.  Predictors of loss of lung function in the elderly: the Cardiovascular Health Study.

Authors:  K A Griffith; D L Sherrill; E M Siegel; T A Manolio; H W Bonekat; P L Enright
Journal:  Am J Respir Crit Care Med       Date:  2001-01       Impact factor: 21.405

2.  Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. The Lung Health Study.

Authors:  P D Scanlon; J E Connett; L A Waller; M D Altose; W C Bailey; A S Buist; D P Tashkin
Journal:  Am J Respir Crit Care Med       Date:  2000-02       Impact factor: 21.405

3.  Respiratory muscle strength and the risk of incident cardiovascular events.

Authors:  J van der Palen; T D Rea; T A Manolio; T Lumley; A B Newman; R P Tracy; P L Enright; B M Psaty
Journal:  Thorax       Date:  2004-12       Impact factor: 9.139

4.  Discrepancy in the use of confirmatory tests in patients hospitalized with the diagnosis of chronic obstructive pulmonary disease or congestive heart failure.

Authors:  Mahendra Damarla; Bartolome R Celli; Hana X Mullerova; Victor M Pinto-Plata
Journal:  Respir Care       Date:  2006-10       Impact factor: 2.258

Review 5.  The relationship between reduced lung function and cardiovascular mortality: a population-based study and a systematic review of the literature.

Authors:  Don D Sin; LieLing Wu; S F Paul Man
Journal:  Chest       Date:  2005-06       Impact factor: 9.410

6.  Chronic obstructive pulmonary disease in the older adult: what defines abnormal lung function?

Authors:  David M Mannino; A Sonia Buist; William M Vollmer
Journal:  Thorax       Date:  2006-11-07       Impact factor: 9.139

7.  Lung function and incident coronary heart disease: the Atherosclerosis Risk in Communities Study.

Authors:  Emily B Schroeder; Verna Lamar Welch; David Couper; F Javier Nieto; Duanping Liao; Wayne D Rosamond; Gerardo Heiss
Journal:  Am J Epidemiol       Date:  2003-12-15       Impact factor: 4.897
  7 in total
  1 in total

1.  Clinical relevance of fixed ratio vs lower limit of normal of FEV1/FVC in COPD: patient-reported outcomes from the CanCOLD cohort.

Authors:  Wouter van Dijk; Wan Tan; Pei Li; Best Guo; Summer Li; Andrea Benedetti; Jean Bourbeau
Journal:  Ann Fam Med       Date:  2015 Jan-Feb       Impact factor: 5.166
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.